Applicability of phase 3 trial selection criteria to real-world transthyretin amyloid cardiomyopathy patients

M Michael Poledniczek L Lena Marie Schmid C Christina Kronberger N Nikita Ermolaev R René Rettl C Christina Binder L Luciana Camuz Ligios M Mahshid Eslami C Christian Nitsche C Christian Hengstenberg R Roza Badr Eslam A Andreas Kammerlander J Johannes Kästner (Institute for Theoretical Chemistry, University of Stuttgart, Pfaffenwaldring 55, Stuttgart 70569, Germany) J Jutta Bergler-Klein FESC F Franz Duca

Article Details

Volume / Issue Vol. 15, Issue 1
Published October 29, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (15)

M

Michael Poledniczek

L

Lena Marie Schmid

C

Christina Kronberger

N

Nikita Ermolaev

R

René Rettl

C

Christina Binder

L

Luciana Camuz Ligios

M

Mahshid Eslami

C

Christian Nitsche

C

Christian Hengstenberg

R

Roza Badr Eslam

A

Andreas Kammerlander

J

Johannes Kästner

Institute for Theoretical Chemistry, University of Stuttgart, Pfaffenwaldring 55, Stuttgart 70569, Germany

J

Jutta Bergler-Klein FESC

F

Franz Duca